13F

Stock

Propanc Biopharma, Inc.

PPCB · held by 6 managers

Reported value

$44.7K

Holders

6

+4 new · −3 exited

Holders’ est. mark

−$33.5K

Price effect on 2 books still in the name

Largest holder

$19.4K

UBS Group AG

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
UBS Group AG182.6K$19.4KNew
JANE STREET GROUP, LLC143.2K$15.2KNew
Marex Group plc67.7K$7.18K−$28.2KCut−$27.9K
Sassicaia Capital Advisers LLC16K$1.7KNew
XTX Topco Ltd12.1K$1.28K−$5.25KCut−$10.7K
Virtu Financial LLC40.7K$4New

Who left

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.